Matches in Wikidata for { <http://www.wikidata.org/entity/Q38092447> ?p ?o ?g. }
- Q38092447 description "article científic" @default.
- Q38092447 description "article scientifique" @default.
- Q38092447 description "articol științific" @default.
- Q38092447 description "articolo scientifico" @default.
- Q38092447 description "artigo científico" @default.
- Q38092447 description "artigo científico" @default.
- Q38092447 description "artigo científico" @default.
- Q38092447 description "artikel ilmiah" @default.
- Q38092447 description "artikull shkencor" @default.
- Q38092447 description "artículo científico" @default.
- Q38092447 description "artículu científicu espublizáu en 2013" @default.
- Q38092447 description "bilimsel makale" @default.
- Q38092447 description "scienca artikolo" @default.
- Q38092447 description "scientific article published on 20 March 2013" @default.
- Q38092447 description "scientific article published on 20 March 2013" @default.
- Q38092447 description "scientific article published on 20 March 2013" @default.
- Q38092447 description "vedecký článok" @default.
- Q38092447 description "vetenskaplig artikel" @default.
- Q38092447 description "videnskabelig artikel" @default.
- Q38092447 description "vitenskapelig artikkel" @default.
- Q38092447 description "vitskapeleg artikkel" @default.
- Q38092447 description "vědecký článek" @default.
- Q38092447 description "wetenschappelijk artikel" @default.
- Q38092447 description "wissenschaftlicher Artikel" @default.
- Q38092447 description "наукова стаття, опублікована в березні 2013" @default.
- Q38092447 description "научная статья" @default.
- Q38092447 description "научни чланак" @default.
- Q38092447 description "מאמר מדעי" @default.
- Q38092447 description "مقالة علمية نشرت في 20 مارس 2013" @default.
- Q38092447 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38092447 name "Active surveillance of very-low-risk prostate cancer in the setting of active treatment of benign prostatic hyperplasia with 5α-reductase inhibitors" @default.
- Q38092447 name "Active surveillance of very-low-risk prostate cancer in the setting of active treatment of benign prostatic hyperplasia with 5α-reductase inhibitors" @default.
- Q38092447 name "Active surveillance of very-low-risk prostate cancer in the setting of active treatment of benign prostatic hyperplasia with 5α-reductase inhibitors" @default.
- Q38092447 type Item @default.
- Q38092447 label "Active surveillance of very-low-risk prostate cancer in the setting of active treatment of benign prostatic hyperplasia with 5α-reductase inhibitors" @default.
- Q38092447 label "Active surveillance of very-low-risk prostate cancer in the setting of active treatment of benign prostatic hyperplasia with 5α-reductase inhibitors" @default.
- Q38092447 label "Active surveillance of very-low-risk prostate cancer in the setting of active treatment of benign prostatic hyperplasia with 5α-reductase inhibitors" @default.
- Q38092447 prefLabel "Active surveillance of very-low-risk prostate cancer in the setting of active treatment of benign prostatic hyperplasia with 5α-reductase inhibitors" @default.
- Q38092447 prefLabel "Active surveillance of very-low-risk prostate cancer in the setting of active treatment of benign prostatic hyperplasia with 5α-reductase inhibitors" @default.
- Q38092447 prefLabel "Active surveillance of very-low-risk prostate cancer in the setting of active treatment of benign prostatic hyperplasia with 5α-reductase inhibitors" @default.
- Q38092447 P1433 Q38092447-204F464B-8B0F-4192-81AA-F6B1BEDF6A8F @default.
- Q38092447 P1476 Q38092447-8FD81673-F4D2-48D1-869A-E4D06A434F35 @default.
- Q38092447 P2093 Q38092447-04AF5D04-5664-495C-B6C6-35BFDD4698B3 @default.
- Q38092447 P2093 Q38092447-0CDCD81F-A4F6-4669-B02F-7C5A0E4CDA78 @default.
- Q38092447 P2093 Q38092447-0D266D04-DAC1-4D9B-89FD-AAF0A2F1105A @default.
- Q38092447 P2093 Q38092447-785830EA-E859-42F3-AB04-91E1644B916B @default.
- Q38092447 P2093 Q38092447-DE8CB8B0-8908-4D76-8A85-66931C3E8997 @default.
- Q38092447 P2093 Q38092447-E21CFBFB-7523-4226-BF95-FD1A8CEE15E3 @default.
- Q38092447 P2093 Q38092447-E8B28F2F-A227-4BC3-9974-2CA74B6576CF @default.
- Q38092447 P2860 Q38092447-527B03CE-322B-470B-89C9-D9255A8B2872 @default.
- Q38092447 P2860 Q38092447-53B41FAA-0259-4503-B973-F3D91305B527 @default.
- Q38092447 P2860 Q38092447-5C499A72-BF5E-46E6-9D9E-988AC27C040A @default.
- Q38092447 P2860 Q38092447-6709E0F2-4B36-4C20-89A6-324F544F50DC @default.
- Q38092447 P2860 Q38092447-6D07CDED-1185-4553-99F1-B2F056F65FF4 @default.
- Q38092447 P2860 Q38092447-77EC457A-BE91-47DC-9CFE-A098EFA0822C @default.
- Q38092447 P2860 Q38092447-7E20D99E-9DDF-4E35-9EB8-614ED98F8871 @default.
- Q38092447 P2860 Q38092447-96519AEC-40B6-4153-83F7-2650A866E69C @default.
- Q38092447 P2860 Q38092447-9D3F6F48-853C-4373-BD14-72F864E2678E @default.
- Q38092447 P2860 Q38092447-B4049CE0-F273-4315-AABD-6A03233E8999 @default.
- Q38092447 P2860 Q38092447-BA9AECE7-5096-491C-A2A2-829169B11C2E @default.
- Q38092447 P2860 Q38092447-E43666C8-8894-4AD4-A7D5-5D33D755A565 @default.
- Q38092447 P2860 Q38092447-E509E3D4-479B-4064-9D90-374D72A763D3 @default.
- Q38092447 P304 Q38092447-F61B3929-87B4-4CDF-BBFA-B218310698E6 @default.
- Q38092447 P31 Q38092447-7980BF3D-1CDE-4E90-A6AF-D1051CDC5C2F @default.
- Q38092447 P356 Q38092447-524AF3A7-0028-4727-A9F9-CA9D927399EC @default.
- Q38092447 P407 Q38092447-E07C53F3-AC8D-4A7B-9BA6-512391DAB06F @default.
- Q38092447 P433 Q38092447-7941C24D-1717-4BD9-8E5A-8CB60D355A63 @default.
- Q38092447 P478 Q38092447-645B670C-2B5D-43B7-9CCB-36887014DD7B @default.
- Q38092447 P577 Q38092447-6CE3B971-F68C-4CDF-B3C4-6CABE5C14AE5 @default.
- Q38092447 P698 Q38092447-7C29879B-1C3A-49F3-9909-11DAFC5C7F9F @default.
- Q38092447 P921 Q38092447-227996D9-BA14-4CB1-B99F-BDCF03B94FBB @default.
- Q38092447 P356 J.UROLOGY.2012.10.089 @default.
- Q38092447 P698 23523297 @default.
- Q38092447 P1433 Q7900884 @default.
- Q38092447 P1476 "Active surveillance of very-low-risk prostate cancer in the setting of active treatment of benign prostatic hyperplasia with 5α-reductase inhibitors" @default.
- Q38092447 P2093 "Allie N Ivanowicz" @default.
- Q38092447 P2093 "Carolyn M Wakeman" @default.
- Q38092447 P2093 "Chris M Teigland" @default.
- Q38092447 P2093 "James Norton" @default.
- Q38092447 P2093 "Michael G Rydberg" @default.
- Q38092447 P2093 "Peter Q Shelton" @default.
- Q38092447 P2093 "Stephen B Riggs" @default.
- Q38092447 P2860 Q28241157 @default.
- Q38092447 P2860 Q37319677 @default.
- Q38092447 P2860 Q37449801 @default.
- Q38092447 P2860 Q39805030 @default.
- Q38092447 P2860 Q46699333 @default.
- Q38092447 P2860 Q50592808 @default.
- Q38092447 P2860 Q59575094 @default.
- Q38092447 P2860 Q62778223 @default.
- Q38092447 P2860 Q63966029 @default.
- Q38092447 P2860 Q80917895 @default.
- Q38092447 P2860 Q81234810 @default.
- Q38092447 P2860 Q82451589 @default.
- Q38092447 P2860 Q83442769 @default.
- Q38092447 P304 "979-984" @default.
- Q38092447 P31 Q13442814 @default.
- Q38092447 P356 "10.1016/J.UROLOGY.2012.10.089" @default.
- Q38092447 P407 Q1860 @default.
- Q38092447 P433 "5" @default.